Search | Page 24 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

    ... patients, and provides an impetus to reduce exposure to chemotherapy and radiotherapy in preparative regimens. Recent studies ...

    Clinical Trial last updated 04/27/2016 - 8:49am.

  2. Options for MDS patients beyond HMAs

    ... including:  low dose cytarabine; aggressive chemotherapy ; switching to the other of the two HMAs – preferably ...

    Research Review last updated 05/02/2016 - 9:09am.

  3. "You Can't Beat Me!"

    ... in Baltimore, where he went through an intense high-dose chemotherapy treatment to reboot his immune system. Taking ten different ...

    Patient Chronicle last updated 04/25/2016 - 10:47am.

  4. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... NHL in remission which is considered not curable with chemotherapy alone and not eligible/appropriate for autologous transplant. ... have achieved at least partial response following additional chemotherapy. Patients with high risk cytogenetics at diagnosis ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  5. Nonmyeloablative Haploidentical Transplant Followed by MLN9708

    ... blast crisis in 2nd chronic phase following induction chemotherapy ) Acute Myelogenous Leukemia (2nd or subsequent complete remission [CR] (OR) Primary induction chemotherapy failure, but subsequently entered into a CR(OR) 1st CR with poor ...

    Clinical Trial last updated 04/29/2016 - 1:05pm.

  6. Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    ... or who require a bone marrow donor search may receive chemotherapy first. Donors will provide bone marrow for transplant ... will receive 4 days of radiation followed by 2-4 days of chemotherapy before the bone marrow transplant (depending on age). Recipients ...

    Clinical Trial last updated 04/28/2016 - 11:14am.

  7. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... metastases and did not achieve a CR with surgery and/or chemotherapy Karnofsky (patients > 16 years) or Lansky ... have fully recovered from acute toxic effects of all prior chemotherapy, immunotherapy, or radiotherapy prior to entering this study ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  8. Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

    ... the body, or myeloproliferative neoplasm. Drugs used in chemotherapy , such as decitabine and cytarabine, work in different ways to ...

    Clinical Trial last updated 04/21/2016 - 1:23pm.

  9. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... NHL in remission which is considered not curable with chemotherapy alone and not eligible/appropriate for autologous transplant. ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  10. Diagnosis

    ... you been exposed to harmful chemicals? Did you have chemotherapy or radiation treatments in the past? Is your urine dark or ...

    Topic section last updated 04/19/2016 - 3:35pm.